Werner Lanthaler
Direktor/Vorstandsmitglied bei AC IMMUNE SA
Vermögen: 16 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Andrea Pfeifer | M | 66 | 21 Jahre | |
Douglas Williams | M | 66 | 6 Jahre | |
Mario Polywka | M | 61 | 20 Jahre | |
Craig Johnstone | M | 54 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | 12 Jahre |
Iris Löw-Friedrich | M | 63 | 10 Jahre | |
Anthony Adam Rosenberg | M | 71 | 7 Jahre | |
Monika Bütler | M | 63 | 3 Jahre | |
Monica Shaw | M | 46 | 3 Jahre | |
Oliver Sol | M | 58 | 8 Jahre | |
Christopher Roberts | M | 35 | 5 Jahre | |
Ana Cespedes | M | 51 | 2 Jahre | |
Roy Ervin Twyman | M | 68 | 5 Jahre | |
Beth Delgiacco | F | - | 6 Jahre | |
Camilla Sylvest | F | 52 | 2 Jahre | |
Piergiorgio Donati | M | 54 | 6 Jahre | |
Steve Krognes | M | 56 | 1 Jahre | |
Gary Waanders | M | 60 | - | |
Laetitia Rouxel | F | 51 | 1 Jahre | |
James Daly | M | 63 | 6 Jahre | |
Jean-Fabien Monin | M | 54 | 15 Jahre | |
Carl June | M | 70 | 4 Jahre | |
Joseph deBethizy | M | 74 | 9 Jahre | |
Pamela Klein | M | 63 | 8 Jahre | |
Filip Borgions | M | - | 9 Jahre | |
Hemamalini Moorthy | F | 54 | 2 Jahre | |
Luc Truyen | M | 59 | 2 Jahre | |
Karl Gubitz | M | 54 | 3 Jahre | |
Peter Ulrichts | M | 44 | 1 Jahre | |
Julian Snow | M | - | - | |
Hinnerk Rohwedder | M | - | 3 Jahre | |
Howard Donovan | M | 49 | 2 Jahre | |
Matthias Evers | M | 51 | 2 Jahre | |
Constanze Ulmer-Eilfort | M | 62 | 3 Jahre | |
Ralph Spillner | M | 54 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | - |
Mark Danton | M | 60 | 5 Jahre | |
Bojana Portmann | M | 43 | 13 Jahre | |
Marc Schorpion | M | 66 | 6 Jahre | |
Arjen Lemmen | M | 39 | 8 Jahre | |
Julien Rongère | M | 47 | 7 Jahre | |
Alexandre Caratsch | M | 59 | 6 Jahre | |
Christophe Muller | M | 53 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | - |
Camilla Languille | F | 41 | 2 Jahre | |
Elaine Sullivan | M | 63 | 9 Jahre | |
Madiha Derouazi | M | 51 | - | |
Sonia Maria Poli | M | 59 | 7 Jahre | |
Kari Kapsch | M | 60 |
Federation of Austrian Industry
Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | 25 Jahre |
Cord Dohrmann | M | 60 | 14 Jahre | |
Roland Sackers | M | 56 | 5 Jahre | |
Nuno Mendonça | M | 42 | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Reinhard Kandera | M | 54 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 12 Jahre |
Thomas Lingelbach | M | 60 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 7 Jahre |
Eric Castaldi | M | 59 | 7 Jahre | |
Timm H. Jessen | M | 62 |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | 5 Jahre |
Martin Velasco | M | 70 | 18 Jahre | |
Peter Bollmann | M | 71 | 6 Jahre | |
Wolfgang Plischke | M | 72 | 7 Jahre | |
Charmion Gillmore | F | - | - | |
David Lacey | M | 71 | 7 Jahre | |
Thomas Graney | M | 60 | 7 Jahre | |
Claus Tycho Bræstrup | M | 79 | - | |
Walter Wenninger | M | 86 | 6 Jahre | |
Michel Gréco | M | 80 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 Jahre |
Bernd Hirsch | M | 53 | - | |
James Sulat | M | 73 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 Jahre |
Friedrich von Bohlen und Halbach | M | 60 | 5 Jahre | |
Mustapha Bakali | M | 62 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 6 Jahre |
Alan Colowick | M | 61 | 2 Jahre | |
Paul Herrling | M | 78 | 3 Jahre | |
Johannes Streffer | M | 56 | 2 Jahre | |
Marie Kosco-Vilbois | M | 67 | 5 Jahre | |
Andreas Muhs | M | 62 | 13 Jahre | |
Kasim Kutay | M | 59 | - | |
Dirk Beeusaert | M | 59 | 5 Jahre | |
Michael Shalmi | M | 59 | - | |
Monika Conradt | F | - | - | |
Andreas Pinkwart | M | 64 | 3 Jahre | |
Cony D’Cruz | M | 62 | 9 Jahre | |
Wim Parys | M | 64 | 3 Jahre | |
Yvonne Greenstreet | M | 61 | 1 Jahre | |
R. Woods | M | 57 | 5 Jahre | |
Nicolas Leupin | M | 50 | 3 Jahre | |
Jeffrey Farrow | M | 62 | 2 Jahre | |
Roman Necina | M | 56 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 4 Jahre |
Peter John Fellner | M | 80 | 6 Jahre | |
Paul Sekhri | M | 65 |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | - |
David Ebsworth | M | 69 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 Jahre |
Roland Oetker | M | 75 | 3 Jahre | |
Michael Bart Sheffery | M | 73 | - | |
Bruno Montanari | M | 49 | 7 Jahre | |
Corey Goodman | M | 72 | 2 Jahre | |
Gregory Glenn | M | 70 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 Jahre |
Tim Tasker | M | 70 | - | |
Harrold van Barlingen | M | 58 | 7 Jahre | |
Veit Sorger | M | 81 |
Federation of Austrian Industry
Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | - |
Colin Bond | M | 64 | 6 Jahre | |
Enno Spillner | M | 55 | 7 Jahre | |
Mary C. Tanner | F | 73 | 9 Jahre | |
John Paul de Koning | M | 55 | 8 Jahre | |
Gerd Zettlmeissl | M | 68 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 Jahre |
Leesa Gentry | F | 54 | 13 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Deutschland | 33 | 33,00% |
Schweiz | 28 | 28,00% |
Niederlande | 26 | 26,00% |
Österreich | 11 | 11,00% |
Vereinigtes Königreich | 3 | 3,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Werner Lanthaler
- Persönliches Netzwerk